228 related articles for article (PubMed ID: 24369049)
1. Variant GADL1 and response to lithium therapy in bipolar I disorder.
Chen CH; Lee CS; Lee MT; Ouyang WC; Chen CC; Chong MY; Wu JY; Tan HK; Lee YC; Chuo LJ; Chiu NY; Tsang HY; Chang TJ; Lung FW; Chiu CH; Chang CH; Chen YS; Hou YM; Chen CC; Lai TJ; Tung CL; Chen CY; Lane HY; Su TP; Feng J; Lin JJ; Chang CJ; Teng PR; Liu CY; Chen CK; Liu IC; Chen JJ; Lu T; Fan CC; Wu CK; Li CF; Wang KH; Wu LS; Peng HL; Chang CP; Lu LS; Chen YT; Cheng AT;
N Engl J Med; 2014 Jan; 370(2):119-28. PubMed ID: 24369049
[TBL] [Abstract][Full Text] [Related]
2. Effects of GADL1 overexpression on cell migration and the associated morphological changes.
Wu TN; Chen CK; Liu IC; Wu LS; Cheng AT
Sci Rep; 2019 Mar; 9(1):5298. PubMed ID: 30923325
[TBL] [Abstract][Full Text] [Related]
3. Variant GADL1 and response to lithium in bipolar I disorder.
Anghelescu I; Dettling M
N Engl J Med; 2014 May; 370(19):1859. PubMed ID: 24806177
[No Abstract] [Full Text] [Related]
4. Variant GADL1 and response to lithium in bipolar I disorder.
; Hou L; Heilbronner U; Rietschel M; Kato T; Kuo PH; McMahon FJ; Schulze TG
N Engl J Med; 2014 May; 370(19):1857-9. PubMed ID: 24806176
[No Abstract] [Full Text] [Related]
5. Variant GADL1 and response to lithium in bipolar I disorder.
Ikeda M; Kondo K; Iwata N
N Engl J Med; 2014 May; 370(19):1856-7. PubMed ID: 24806175
[No Abstract] [Full Text] [Related]
6. Variant GADL1 and response to lithium in bipolar I disorder.
Vlachadis N; Vrachnis N; Economou E
N Engl J Med; 2014 May; 370(19):1856. PubMed ID: 24806174
[No Abstract] [Full Text] [Related]
7. Variant GADL1 and response to lithium in bipolar I disorder.
Birnbaum R; Shin JH; Weinberger D
N Engl J Med; 2014 May; 370(19):1855-6. PubMed ID: 24806173
[No Abstract] [Full Text] [Related]
8. Variant GADL1 and response to lithium in bipolar I disorder.
Lee CS; Cheng AT
N Engl J Med; 2014 May; 370(19):1859-60. PubMed ID: 24806172
[No Abstract] [Full Text] [Related]
9. Lithium response in bipolar disorder: No difference in GADL1 gene expression between cell lines from excellent-responders and non-responders.
Moreira J; Courtin C; Geoffroy PA; Curis E; Bellivier F; Marie-Claire C
Psychiatry Res; 2017 May; 251():217-220. PubMed ID: 28214779
[TBL] [Abstract][Full Text] [Related]
10. Lithium and GADL1 regulate glycogen synthase kinase-3 activity to modulate KCTD12 expression.
Wu TN; Chen CK; Lee CS; Wu BJ; Sun HJ; Chang CH; Chen CY; Wu LS; Cheng AT
Sci Rep; 2019 Jul; 9(1):10255. PubMed ID: 31311980
[TBL] [Abstract][Full Text] [Related]
11. Immunophenotypes associated with bipolar disorder and lithium treatment.
Wu TN; Lee CS; Wu BJ; Sun HJ; Chang CH; Chen CY; Chen CK; Wu LS; Cheng AT
Sci Rep; 2019 Nov; 9(1):17453. PubMed ID: 31767892
[TBL] [Abstract][Full Text] [Related]
12. No evidence for GADL1 variation as a bipolar disorder susceptibility factor in a Caucasian lithium-responsive cohort.
Cruceanu C; Alda M; Dion PA; Turecki G; Rouleau GA
Am J Psychiatry; 2015 Jan; 172(1):94-5. PubMed ID: 25553497
[No Abstract] [Full Text] [Related]
13. GADL1 gene polymorphisms and lithium response in bipolar I disorder: lack of association from an Indian population.
Kotambail A; Mathur A; Bhat SM; Rai PS; Sharma PS; Satyamoorthy K
Psychiatr Genet; 2015 Feb; 25(1):39-40. PubMed ID: 25415457
[No Abstract] [Full Text] [Related]
14.
Chen CK; Lee CS; Chen HY; Wu LS; Chang JC; Liu CY; Cheng AT
BJPsych Open; 2016 Sep; 2(5):301-306. PubMed ID: 27703793
[TBL] [Abstract][Full Text] [Related]
15. Need exists for genetic predictors of lithium response.
Potash JB; Schulze TG
Evid Based Ment Health; 2014 Aug; 17(3):72. PubMed ID: 24841873
[No Abstract] [Full Text] [Related]
16. Polymorphism of circadian clock genes and prophylactic lithium response.
Rybakowski JK; Dmitrzak-Weglar M; Kliwicki S; Hauser J
Bipolar Disord; 2014 Mar; 16(2):151-8. PubMed ID: 24636202
[TBL] [Abstract][Full Text] [Related]
17. Association of polygenic score and the involvement of cholinergic and glutamatergic pathways with lithium treatment response in patients with bipolar disorder.
Amare AT; Thalamuthu A; Schubert KO; Fullerton JM; Ahmed M; Hartmann S; Papiol S; Heilbronner U; Degenhardt F; Tekola-Ayele F; Hou L; Hsu YH; Shekhtman T; Adli M; Akula N; Akiyama K; Ardau R; Arias B; Aubry JM; Hasler R; Richard-Lepouriel H; Perroud N; Backlund L; Bhattacharjee AK; Bellivier F; Benabarre A; Bengesser S; Biernacka JM; Birner A; Marie-Claire C; Cervantes P; Chen HC; Chillotti C; Cichon S; Cruceanu C; Czerski PM; Dalkner N; Del Zompo M; DePaulo JR; Étain B; Jamain S; Falkai P; Forstner AJ; Frisen L; Frye MA; Gard S; Garnham JS; Goes FS; Grigoroiu-Serbanescu M; Fallgatter AJ; Stegmaier S; Ethofer T; Biere S; Petrova K; Schuster C; Adorjan K; Budde M; Heilbronner M; Kalman JL; Kohshour MO; Reich-Erkelenz D; Schaupp SK; Schulte EC; Senner F; Vogl T; Anghelescu IG; Arolt V; Dannlowski U; Dietrich D; Figge C; Jäger M; Lang FU; Juckel G; Konrad C; Reimer J; Schmauß M; Schmitt A; Spitzer C; von Hagen M; Wiltfang J; Zimmermann J; Andlauer TFM; Fischer A; Bermpohl F; Ritter P; Matura S; Gryaznova A; Falkenberg I; Yildiz C; Kircher T; Schmidt J; Koch M; Gade K; Trost S; Haussleiter IS; Lambert M; Rohenkohl AC; Kraft V; Grof P; Hashimoto R; Hauser J; Herms S; Hoffmann P; Jiménez E; Kahn JP; Kassem L; Kuo PH; Kato T; Kelsoe J; Kittel-Schneider S; Ferensztajn-Rochowiak E; König B; Kusumi I; Laje G; Landén M; Lavebratt C; Leboyer M; Leckband SG; Tortorella A; Manchia M; Martinsson L; McCarthy MJ; McElroy S; Colom F; Millischer V; Mitjans M; Mondimore FM; Monteleone P; Nievergelt CM; Nöthen MM; Novák T; O'Donovan C; Ozaki N; Pfennig A; Pisanu C; Potash JB; Reif A; Reininghaus E; Rouleau GA; Rybakowski JK; Schalling M; Schofield PR; Schweizer BW; Severino G; Shilling PD; Shimoda K; Simhandl C; Slaney CM; Squassina A; Stamm T; Stopkova P; Maj M; Turecki G; Vieta E; Veeh J; Witt SH; Wright A; Zandi PP; Mitchell PB; Bauer M; Alda M; Rietschel M; McMahon FJ; Schulze TG; Clark SR; Baune BT
Mol Psychiatry; 2023 Dec; 28(12):5251-5261. PubMed ID: 37433967
[TBL] [Abstract][Full Text] [Related]
18. Evidence for association of an ACCN1 gene variant with response to lithium treatment in Sardinian patients with bipolar disorder.
Squassina A; Manchia M; Borg J; Congiu D; Costa M; Georgitsi M; Chillotti C; Ardau R; Mitropoulos K; Severino G; Del Zompo M; Patrinos GP
Pharmacogenomics; 2011 Nov; 12(11):1559-69. PubMed ID: 21961650
[TBL] [Abstract][Full Text] [Related]
19. A glutamatergic network mediates lithium response in bipolar disorder as defined by epigenome pathway analysis.
Higgins GA; Allyn-Feuer A; Barbour E; Athey BD
Pharmacogenomics; 2015; 16(14):1547-63. PubMed ID: 26343379
[TBL] [Abstract][Full Text] [Related]
20. A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder.
Perlis RH; Smoller JW; Ferreira MA; McQuillin A; Bass N; Lawrence J; Sachs GS; Nimgaonkar V; Scolnick EM; Gurling H; Sklar P; Purcell S
Am J Psychiatry; 2009 Jun; 166(6):718-25. PubMed ID: 19448189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
